Relapsed B-Cell Non-Hodgkin Lymphoma
Also known as: Relapsed B-cell NHL
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16371 | Glofitamab | 1 | Recruiting | 1 |
| DB16222 | Loncastuximab tesirine | 1 | Recruiting | 1 |
| DB15434 | Mosunetuzumab | 1 | Recruiting | 1 |
| DB08935 | Obinutuzumab | 1 | Recruiting | 1 |
| DB12240 | Polatuzumab vedotin | 1 | Recruiting | 1 |
| DB00480 | Lenalidomide | 2 | Recruiting | 1 |
| DB15434 | Mosunetuzumab | 2 | Recruiting | 1 |
| DB12240 | Polatuzumab vedotin | 2 | Recruiting | 1 |
| DB15044 | Tafasitamab | 2 | Recruiting | 1 |